Nicole Raus
About
Nicole Raus is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology.
According to data from OpenAlex, Nicole Raus has authored 23 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Nicole Raus's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Nicole Raus is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Nicole Raus collaborates with scholars based in France, Belgium and Switzerland. Nicole Raus's co-authors include Didier Blaise, Mauricette Michallet, Karin Bilger, Gèrard Socié, Jean‐Yves Cahn, Philippe Moreau, Mathieu Kuentz, Xavier Thomas, Nöel Milpied and Ibrahim Yakoub‐Agha and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Haematologica.
In The Last Decade
Nicole Raus
21 papers receiving 257 citations
Peers
Nicole Raus
M A Kharfan-Dabaja United States
Hee‐Je Kim South Korea
Nathalie Aladjidi France
Giovanni Rossi Italy
Cristina Barrenetxea Spain
S. Fürst France
K. Wolownik United States
Ahsan Chaudhry Canada
Julie Arrazi United Kingdom
Lisandro Ribeiro Brazil
Citations per year, relative to Nicole Raus Nicole Raus (= 1×)
peers
M A Kharfan-Dabaja
Countries citing papers authored by Nicole Raus
Since
Specialization
Citations
This map shows the geographic impact of Nicole Raus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Raus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Raus more than expected).
Fields of papers citing papers by Nicole Raus
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nicole Raus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Raus. The network helps show where Nicole Raus may publish in the future.
Co-authorship network of co-authors of Nicole Raus
This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Raus. A scholar is included among the top collaborators of Nicole Raus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Raus. Nicole Raus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Michonneau, David, Florent Malard, Léonardo Magro, et al.. (2025). Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation. 60(6). 779–786.
2.
Chevret, Sylvie, Xavier Poiré, Magalie Joris, et al.. (2024). Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation. 59(7). 965–973.
3.
Saultier, Paul, Gérard Michel, Anne Sîrvent, et al.. (2023). Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia. Blood. 142(Supplement 1). 3762–3762.
4.
Broussais, Florence, et al.. (2021). Lettre type pour les comptes rendus « CAR-T Cells » : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. 108(12). S82–S86.
5.
Chaillou, Delphine, et al.. (2019). Saisie des données des patients faisant l’objet d’un traitement par cellules CAR-T : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. 107(12). S178–S184.
6.
Raus, Nicole, et al.. (2019). Modalités de capture des anomalies cytogénétiques et moléculaires pour la leucémie aiguë, le myélome multiple, le syndrome myélodysplasique, le syndrome myéloprolifératif et le syndrome myélodysplasique/myéloprolifératif : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(1). S52–S61.
7.
Robin, Christine, Catherine Cordonnier, Karine Sitbon, et al.. (2018). Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation. 25(2). 354–361.
8.
Detrait, Marie Y., Stéphane Morisset, Yves Chalandon, et al.. (2015). Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French–Swiss retrospective study. Bone Marrow Transplantation. 50(10). 1316–1320.
9.
Leclerc, Mathieu, Régis Peffault de Latour, Mauricette Michallet, et al.. (2015). Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). Blood. 126(23). 3208–3208.
10.
Detrait, Marie Y., Stéphane Morisset, Régis Peffault de Latour, et al.. (2014). Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation. 50(2). 253–258.
11.
Chevallier, Patrice, Myriam Labopin, Gèrard Socié, et al.. (2014). Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM ‐TC . European Journal Of Haematology. 94(5). 449–455.
12.
Tifratène, Karim, Nicole Raus, Gèrard Socié, et al.. (2014). Outcome after Relapse or Progression Following First Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia. a Retrospective Analysis from the French Society of Bone Marrow Transplantation and Cell Therapies. Blood. 124(21). 2510–2510.
13.
Chevallier, Patrice, Myriam Labopin, Nöel Milpied, et al.. (2013). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation. 49(3). 361–365.
14.
Dhédin, Nathalie, Anne Huynh, Sébastien Maury, et al.. (2013). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL). Blood. 122(21). 552–552.
15.
Lebon, Delphine, Marie Thérèse Rubio, Faézeh Legrand, et al.. (2013). Ruxolitinib For Patients With Primary Or Secondary Myelofibrosis before Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): A Retrospective Study Of The Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC). Blood. 122(21). 2111–2111.
16.
Chantepie, Sylvain, Mohamad Mohty, Reza Tabrizi, et al.. (2012). Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation. 48(5). 684–690.
17.
Larosa, Fabrice, Faézeh Legrand, Brigitte Witz, et al.. (2010). G-CSF–induced aneuploidy does not affect CD34+ cells and does not require cell division. Blood. 115(4). 910–911.
18.
Michallet, Mauricette, Quoc‐Hung Le, Anne Thiébaut, et al.. (2007). Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.. Blood. 110(11). 3048–3048.
19.
Morfin, Florence, Karin Bilger, Fatiha Najioullah, et al.. (2004). HSV excretion after bone marrow transplantation: a 4-year survey. Journal of Clinical Virology. 30(4). 341–345.
20.
Delannoy, Bertrand, Franck E. Nicolini, Quoc‐Hung Le, et al.. (2004). Impact on Transplant Outcome of Karyotyping Analysis in Apheresis Products for Autologous PBSC Transplantation in De Novo Acute Leukemias (AL).. Blood. 104(11). 1871–1871.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M A Kharfan-Dabaja Breakdown of academic impact, for papers by Hee‐Je Kim Breakdown of academic impact, for papers by Nathalie Aladjidi Breakdown of academic impact, for papers by Giovanni Rossi Breakdown of academic impact, for papers by Cristina Barrenetxea Breakdown of academic impact, for papers by S. Fürst Breakdown of academic impact, for papers by K. Wolownik Breakdown of academic impact, for papers by Ahsan Chaudhry Breakdown of academic impact, for papers by Julie Arrazi Breakdown of academic impact, for papers by Lisandro Ribeiro